Cardiovascular Clinical Trials in Seoul
26 recruitingSeoul, South Korea
Showing 1–20 of 26 trials
Recruiting
Product Surveillance Registry
Cardiac Rhythm DisordersDigestive disordersMinimally Invasive Surgical Procedures+13 more
Medtronic100,000 enrolled395 locationsNCT01524276
Recruiting
Phase 3
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
HypertensionHigh Risk Cardiovascular DiseaseHigh Cardiovascular Risk
Alnylam Pharmaceuticals11,000 enrolled856 locationsNCT07181109
Recruiting
Phase 3
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Cardiovascular DiseasesHypertensionDiabetes Mellitus, Type 2
Boehringer Ingelheim11,800 enrolled1155 locationsNCT07064473
Recruiting
Phase 2Phase 3
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
Atherosclerotic Cardiovascular Disease in Patients With ESKD
CSL Behring3,110 enrolled547 locationsNCT05485961
Recruiting
Phase 3
A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
Chronic Kidney DiseaseAtherosclerosis Cardiovascular Disease
Eli Lilly and Company7,140 enrolled568 locationsNCT07241390
Recruiting
Phase 3
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
Atherosclerotic Cardiovascular Disease (ASCVD)Elevated Lp(a)
Eli Lilly and Company10,450 enrolled752 locationsNCT07157774
Recruiting
Phase 3
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
Cardiovascular Disease
AstraZeneca15,100 enrolled1333 locationsNCT07000357
Recruiting
Phase 3
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
ObesityOverweightAtherosclerotic Cardiovascular Disease
Amgen12,800 enrolled772 locationsNCT07037433
Recruiting
Phase 3
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular RiskAcute Myocardial Infarction (AMI)
Novo Nordisk A/S10,000 enrolled970 locationsNCT06118281
Recruiting
Not Applicable
Further Lipid-Lowering With PCSK9 Inhibitors for Cardiovascular Outcomes in High-Risk Coronary Plaques Assessed by CT Angiography
Coronary Artery DiseaseCardiovascular EventsCT Angiography+1 more
Second Affiliated Hospital, School of Medicine, Zhejiang University3,596 enrolled6 locationsNCT06863545
Recruiting
Phase 4
ASpirin Use and stAtin Strategy for Primary Prevention in Severe Coronary Calcium Score on Computed Tomography
Cardiovascular Diseases
Jung-min Ahn5,000 enrolled1 locationNCT06676280
Recruiting
Not Applicable
Guideline Oriented Approach To Lipid Lowering In Asia-Pacific
Cardiovascular DiseasesAcute Coronary SyndromeAtherosclerosis+1 more
Stephen Nicholls2,000 enrolled22 locationsNCT05325034
Recruiting
Not Applicable
Optimal Target Low-density Lipoprotein Cholesterol Level for Small Vessel Occlusion Stroke
Cardiovascular DiseasesIschemic StrokeSmall Vessel Cerebrovascular Disease+2 more
Seoul National University Hospital4,016 enrolled46 locationsNCT06649240
Recruiting
Phase 2
Efficacy and Safety of SPC1001 in Patients With Essential Hypertension
Cardiovascular DiseasesCardiologyHypertension,Essential
Shin Poong Pharmaceutical Co. Ltd.252 enrolled1 locationNCT06826872
Recruiting
Phase 4
Effect of Ezetimibe on Gut Microbiota
Atherosclerotic Cardiovascular Disease With Dyslipidemia
Yonsei University110 enrolled1 locationNCT06784557
Recruiting
The Oxford Risk Factors And Non-Invasive Imaging Study
Cardiovascular DiseasesCardiovascular Risk Factors
University of Oxford250,000 enrolled37 locationsNCT05169333
Recruiting
Phase 4
Comparison of Clopidogrel-based Antiplatelet Therapy Versus Warfarin As Secondary Prevention Strategy for AntiPhospholipid Syndrome-related STROKE
Cardiovascular DiseasesIschemic StrokeCerebrovascular Disease+3 more
Seoul National University Hospital200 enrolled32 locationsNCT05995600
Recruiting
Phase 4
A Prospective Trial of Enavogliflozin to Evaluate Cardio-renal Outcome in Type 2 Diabetes Mellitus Patients
Cardiovascular DiseasesDiabetes Mellitus, Type 2Kidney Diseases
Yonsei University2,862 enrolled1 locationNCT06642623
Recruiting
Maternal and Offspring Outcomes in Pregnant Women With Pre-existing ASCVD
Cardiovascular DiseasesAtherosclerosisPregnancy Complications+2 more
Samsung Medical Center5,461,222 enrolled1 locationNCT06406998
Recruiting
Phase 4
Effect of Intensive LDL-cholesterol Targeting for Elderly Patients With Cardiovascular Disease: I-OLD Trial
Cardiovascular Disease
Yonsei University1,200 enrolled1 locationNCT05361421